LIVE with Jennifer Kao on the Risk Evaluation On Generic Approvals Of US Pharmaceuticals

LIVE with Jennifer Kao on the Risk Evaluation On Generic Approvals Of US Pharmaceuticals Join us for a free live taping of A Health Podyssey on October 22 where Jennifer Kao will discuss her upcoming paper exploring the impact of risk evaluation and mitigation strategies on generic approvals of US pharmaceutical products. https://us06web.zoom.us/webinar/register/WN_RehBMWZBRS6jwmrnzS11jw?utm_campaign=6508038-Health%20Affairs%20Sunday%20Update%202025&utm_medium=email&_hsenc=p2ANqtz-9WFgOhvPCpweho4AJDzvy0WgVlWlSzaVEMAW2n1FxWrYqfOssMovEMGp_Sz0W5DwLyNSko5x9Z1VJmPs7Ff6Fh8k5W_Q&_hsmi=382459883&utm_content=382459883&utm_source=hs_email#/registration